Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard Schulz

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated ratsMatthias Oelze, Andreas Daiber, Ralf P Brandes, et al.
Echocardiography (Mount Kisco, N.Y.)|August 11, 2020
Feasibility of a MPR-based 3DTEE guidance protocol for transcatheter direct mitral valve annuloplastyMartin Geyer, Efthymios Sotiriou, Karsten Keller, et al.
Clinical Cardiology|September 7, 2022
Survival benefit of overweight patients undergoing MitraClip® procedure in comparison to normal-weight patientsKarsten Keller, Martin Geyer, Lukas Hobohm, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 6, 2011
α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulationSwenja Schuhmacher, Marc Foretz, Maike Knorr, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2008
Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label studyRalf W Dittmann, Eberhard Meyer, Franz Joseph Freisleder, et al.
Diabetes|August 17, 2011
Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapySwenja Schuhmacher, Matthias Oelze, Franziska Bollmann, et al.
Circulation Research|March 9, 2002
Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signalingHanke Mollnau, Maria Wendt, Katalin Szöcs, et al.
Pharmacology|October 6, 2012
Characterization of new organic nitrate hybrid drugs covalently bound to valsartan and cilostazolMaike Knorr, Michael Hausding, Eberhard Schulz, et al.
Pharmacology|June 14, 2014
In vitro and in vivo characterization of a new organic nitrate hybrid drug covalently bound to pioglitazoneMaike Knorr, Michael Hausding, Amanda Pfeffer, et al.
Pharmacology|October 9, 2017
Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and ValsartanMatthias Oelze, Philipp Welschof, Maike Knorr, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated ratsMatthias Oelze, Andreas Daiber, Ralf P Brandes, et al.
Echocardiography (Mount Kisco, N.Y.)|August 11, 2020
Feasibility of a MPR-based 3DTEE guidance protocol for transcatheter direct mitral valve annuloplastyMartin Geyer, Efthymios Sotiriou, Karsten Keller, et al.
Clinical Cardiology|September 7, 2022
Survival benefit of overweight patients undergoing MitraClip® procedure in comparison to normal-weight patientsKarsten Keller, Martin Geyer, Lukas Hobohm, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 6, 2011
α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulationSwenja Schuhmacher, Marc Foretz, Maike Knorr, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2008
Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label studyRalf W Dittmann, Eberhard Meyer, Franz Joseph Freisleder, et al.
Diabetes|August 17, 2011
Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapySwenja Schuhmacher, Matthias Oelze, Franziska Bollmann, et al.
Circulation Research|March 9, 2002
Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signalingHanke Mollnau, Maria Wendt, Katalin Szöcs, et al.
Pharmacology|October 6, 2012
Characterization of new organic nitrate hybrid drugs covalently bound to valsartan and cilostazolMaike Knorr, Michael Hausding, Eberhard Schulz, et al.
Pharmacology|June 14, 2014
In vitro and in vivo characterization of a new organic nitrate hybrid drug covalently bound to pioglitazoneMaike Knorr, Michael Hausding, Amanda Pfeffer, et al.
Pharmacology|October 9, 2017
Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and ValsartanMatthias Oelze, Philipp Welschof, Maike Knorr, et al.
Pageof 14